Jazz Pharmaceuticals Plc Stock Price on January 21, 2025
| JAZZ Stock | USD 120.07 1.46 1.20% |
Below is the normalized historical share price chart for Jazz Pharmaceuticals PLC extending back to June 01, 2007. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Jazz Pharmaceuticals stands at 120.07, as last reported on the 7th of February, with the highest price reaching 122.04 and the lowest price hitting 119.44 during the day.
If you're considering investing in Jazz Stock, it is important to understand the factors that can impact its price. Jazz Pharmaceuticals PLC holds Efficiency (Sharpe) Ratio of -0.0618, which attests that the entity had a -0.0618 % return per unit of risk over the last 3 months. Jazz Pharmaceuticals PLC exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Jazz Pharmaceuticals' Downside Deviation of 1.33, market risk adjusted performance of 0.2295, and Risk Adjusted Performance of 0.0768 to validate the risk estimate we provide.
At this time, Jazz Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 13.8 B in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 51.5 M in 2025. . At this time, Jazz Pharmaceuticals' Price Book Value Ratio is fairly stable compared to the past year. Price To Free Cash Flows Ratio is likely to rise to 9.36 in 2025, whereas Price To Sales Ratio is likely to drop 2.22 in 2025. Jazz Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 1st of June 2007 | 200 Day MA 113.5568 | 50 Day MA 122.8124 | Beta 0.573 |
Jazz |
Sharpe Ratio = -0.0618
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | JAZZ |
Estimated Market Risk
| 1.41 actual daily | 12 88% of assets are more volatile |
Expected Return
| -0.09 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Jazz Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Jazz Pharmaceuticals by adding Jazz Pharmaceuticals to a well-diversified portfolio.
Price Book 1.7614 | Enterprise Value Ebitda 8.3655 | Price Sales 1.818 | Shares Float 58.7 M | Wall Street Target Price 180.9474 |
Jazz Pharmaceuticals Main Headline on 21st of January 2025
Jazz Pharmaceuticals plc Shares Sold by Perpetual Ltd by thelincolnianonline.com
Perpetual Ltd lessened its stake in shares of Jazz Pharmaceuticals plc by 12.0 percent during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 594,388 shares of the specialty pharmaceutical companys stock after selling 81,043 shares during the quarter. Perpetual Ltd owned
Jazz Pharmaceuticals Valuation on January 21, 2025
It is possible to determine the worth of Jazz Pharmaceuticals on a given historical date. On January 21, 2025 Jazz was worth 121.47 at the beginning of the trading date compared to the closed value of 121.43. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Jazz Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Jazz Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Jazz Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Jazz Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 122.52 | 122.77 | 120.79 | 121.18 | 388,673 | |
01/21/2025 | 121.47 | 122.38 | 120.06 | 121.43 | 538,623 |
| 121.55 | 122.29 | 120.34 | 120.84 | 313,901 |
| Backtest Jazz Pharmaceuticals | | | Jazz Pharmaceuticals History | | | Jazz Pharmaceuticals Valuation | Previous | Next |
Jazz Pharmaceuticals Trading Date Momentum on January 21, 2025
| On January 22 2025 Jazz Pharmaceuticals PLC was traded for 120.84 at the closing time. The top price for the day was 122.29 and the lowest listed price was 120.34 . The trading volume for the day was 313.9 K. The trading history from January 22, 2025 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 0.49% . The trading delta at closing time against the current closing price is 3.20% . |
Jazz Pharmaceuticals PLC Fundamentals Correlations and Trends
By evaluating Jazz Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Jazz Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Jazz financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Jazz Pharmaceuticals Stock history
Jazz Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Jazz is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Jazz Pharmaceuticals PLC will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Jazz Pharmaceuticals stock prices may prove useful in developing a viable investing in Jazz Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 82.9 M | 51.5 M | |
| Net Loss | -201.7 M | -191.6 M |
Jazz Pharmaceuticals Quarterly Net Working Capital |
|
Jazz Pharmaceuticals Stock Technical Analysis
Jazz Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Jazz Pharmaceuticals Period Price Range
Low | February 7, 2025
| High |
0.00 | 0.00 |
Jazz Pharmaceuticals PLC cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Jazz Pharmaceuticals February 7, 2025 Market Strength
Market strength indicators help investors to evaluate how Jazz Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Jazz Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Jazz Pharmaceuticals stock market strength indicators, traders can identify Jazz Pharmaceuticals PLC entry and exit signals to maximize returns
Jazz Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Jazz Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Jazz Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Jazz to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0768 | |||
| Jensen Alpha | 0.0819 | |||
| Total Risk Alpha | (0.04) | |||
| Sortino Ratio | 0.0366 | |||
| Treynor Ratio | 0.2195 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Jazz Stock Analysis
When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.